Atherosclerotic and thrombophilic risk factors in patients with ischemic central retinal vein occlusion

Retina

Volumn 31, Issue 4, 2011, Pages 724-729

  Sodi, Andrea ^a   Giambene, Barbara ^a,b   Marcucci, Rossella ^a   Sofi, Francesco ^a   Fedi, Sandra ^a   Abbate, Rosanna ^a   Prisco, Domenico ^a   Menchini, Ugo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; LIPOPROTEIN A; PLASMINOGEN ACTIVATOR INHIBITOR 1; PYRIDOXINE;

AGED; AMINO ACID BLOOD LEVEL; ARTICLE; ATHEROSCLEROSIS; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR 8 ELEVATION; CARDIOVASCULAR RISK; CENTRAL RETINA VEIN OCCLUSION; DIABETES MELLITUS; FEMALE; FOLIC ACID BLOOD LEVEL; FOLIC ACID DEFICIENCY; HUMAN; HYPERCHOLESTEROLEMIA; HYPERHOMOCYSTEINEMIA; HYPERTENSION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PYRIDOXINE DEFICIENCY; SMOKING HABIT; THROMBOPHILIA; VITAMIN BLOOD LEVEL;

ACUTE DISEASE; AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; DYSLIPIDEMIAS; FACTOR VIII; FEMALE; FOLIC ACID; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; HYPERTENSION; ISCHEMIA; MALE; RETINAL VEIN OCCLUSION; RISK FACTORS; THROMBOPHILIA;

EID: 79955075218     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3181eef419     Document Type: Article

References (52)

1. Hayreh SS. Retinal vein occlusion. Indian J Ophthalmol 1994; 42:109-132.
2. Clarkson JG. Central retinal vein occlusion. Ryan SJ, ed. Retina. Vol 2. St Louis, MO: CV Mosby; 2001:1368-1375.
3. Coscas G, Dhermy P. Physiopathologie des occlusions veineuses rétiniennes. Coscas G, Dhermy P, eds. Occlusions Veineuses Rétiniennes. Paris, France: Masson; 1978:77-117.
4. Hayreh SS. Classification of central retinal vein occlusion. Ophthalmology 1983;90:458-474. (Pubitemid 13059774)
5. The Central Vein Occlusion Study Group. Baseline and early natural history report. The Central Vein Occlusion Study. Arch Ophthalmol 1993;111:1087-1095.
6. The Central Vein Occlusion Study Group. A randomized clinical trial of early panretinal photocoagulation for ischemic central vein occlusion. The Central Vein Occlusion Study Group N Report. Ophthalmology 1995;102:1434-1444.
7. The Central Vein Occlusion Study Group. Natural history and clinical management of central retinal vein occlusion. Arch Ophthalmol 1997;115:486-491.
8. The Eye Disease Case-Control Study Group. Risk factors for central retinal vein occlusion. Arch Ophthalmol 1996;114: 545-554.
9. Recchia FM, Brown GC. Systemic disorders associated with retinal vascular occlusion. Curr Opin Ophthalmol 2000;11:462-467.
10. Marcucci R, Bertini L, Giusti B, et al. Thrombophilic risk factors in patients with central retinal vein occlusion. Thromb Haemost 2001;86:772-776. (Pubitemid 32834184)
11. Hayreh SS, Zimmerman B, McCarthy MJ, Podhajsky P. Systemic diseases associated with various types of retinal vein occlusion. Am J Ophthalmol 2001;131:61-77. (Pubitemid 32037010)
12. Prisco D, Marcucci R, Bertini L, Gori AM. Cardiovascular and thrombophilic risk factors for central retinal vein occlusion. Eur J Intern Med 2002;13:163-169. (Pubitemid 34518506)
13. Cahill MT, Stinnett SS, Fekrat S. Meta-analysis of plasma homocysteine, serum folate, serum vitamin B(12), and thermolabile MTHFR genotype as risk factors for retinal vascular occlusive disease. Am J Ophthalmol 2003;136:1136-1150. (Pubitemid 37485782)
14. Gori AM, Marcucci R, Fatini C, et al. Impaired fibrinolysis in retinal vein occlusion: a role for genetic determinants of PAI-1 levels. Thromb Haemost 2004;92:54-60. (Pubitemid 39010867)
15. Janssen MC, sen Heijer M, Cruysberg JR, Wollersheim H, Bredie SJ. Retinal vein occlusion: a form of venous thrombosis or a complication of atherosclerosis? A meta-analysis of thrombophilic factors. Thromb Haemost 2005;93:1021-1026. (Pubitemid 40823503)
16. Sofi F, Mannini L, Marcucci R, et al. Role of haemorheological factors in patients with retinal vein occlusion. Thromb Haemost 2007;98:1215-1219. (Pubitemid 350244409)
17. Cheung N, Klein R, Wang JJ, et al. Traditional and novel cardiovascular risk factors for retinal vein occlusion: the multiethnic study of atherosclerosis. Invest Ophthalmol Vis Sci 2008;49:4297-5302.
18. Cifkova R, Erdine S, Fagard R, et al. Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. Hypertension 2003;21:1779-1786. (Pubitemid 37290093)
19. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26:S5-S20.
20. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143-3421.
21. Weger M, Renner W, Steinbrugger I, et al. Role of thrombophilic gene polymorphisms in branch retinal vein occlusion. Ophthalmology 2005;112:1910-1915. (Pubitemid 41551918)
22. Salaun N, Delyfer MN, Rougier MB, Korobelnik JF. Assessment of risk factors for retinal vein occlusion in patients under 60 years of age. J Fr Ophthalmol 2007;30:918-923.
23. Lim LL, Cheung N, Wang JJ, et al. Prevalence and risk factors of retinal vein occlusion in an Asian population. Br J Ophthalmol 2008;92:1316-1319.
24. O'Mahoney PR,Wong DT, Ray JG. Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch Ophthalmol 2008;126:692-699. (Pubitemid 351679566)
25. Turello M, Pasca S, Daminato R, et al. Retinal vein occlusion: evaluation of "classic" and "emerging" risk factors and treatment. J Thromb Thrombolysis 2010;29:459-464.
26. Sodi A, Giambene B, Marcucci R, et al. Atherosclerotic and thrombophilic risk factors in patients with recurrent central retinal vein occlusion. Eur J Ophthalmol 2008;18:233-238. (Pubitemid 351692183)
27. Vine AK. Hyperhomocysteinemia: a new risk factor for central retinal vein occlusion. Trans Am Ophthalmol Soc 2000;98: 493-503. (Pubitemid 32059520)
28. Adamczuk YP, Iglesias VarelaML, Martinuzzo ME, Cerrato GS, Forastiero RR. Central retinal vein occlusion and thrombophilia risk factors. Blood Coagul Fibrinolysis 2002; 13:623-626. (Pubitemid 35253358)
29. Blondel J, Glacet-Bernard A, Bayani N, et al. Retinal vein occlusion and hyperhomocysteinemia. J Fr Ophthalmol 2003; 26:249-253. (Pubitemid 36722922)
30. Marcucci R, Giusti B, Betti I, et al. Genetic determinants of fasting and post-methionine hyperhomocysteinemia in patients with retinal vein occlusion. Thromb Res 2003;110:7-12. (Pubitemid 36859848)
31. Yildirim C, Yayiali V, Tatlipinar S, Kaptanog¢ lu B, Akpinar S. Hyperhomocysteinemia: a risk factor for retinal vein occlusion. Ophthalmologica 2004;218:102-106. (Pubitemid 38338472)
32. Chua B, Kifley A, Wong TY, Mitchell P. Homocysteine and retinal vein occlusion: a population-based study. Am J Ophthalmol 2005;139:181-182. (Pubitemid 40094858)
33. Narayanasamy A, Subramaniam B, Karunakaran C, et al. Hyperhomocysteinemia and low methionine stress are risk factors for central retinal venous occlusion in an Indian population. Invest Ophthalmol Vis Sci 2007;48:1441-1446. (Pubitemid 351261323)
34. Sottilotta G, Oriana V, Latella C, et al. Role of hyperhomocysteinemia in retinal vascular occlusive disease. Clin Appl Thromb Hemost 2007;13:104-107. (Pubitemid 44905287)
35. Ferrazzi P, Di Micco P, Quaglia I, et al. Homocysteine, MTHFR C677T gene polymorphism, folic acid and vitamin B12 in patients with retinal vein occlusion. Thromb J 2005;3:13.
36. Lattanzio R, Sampietro F, Ramoni A, Fattorini A, Brancato R, D'Angelo A. Moderate hyperhomocysteinemia and early-onset central retinal vein occlusion. Retina 2006;26:65-70. (Pubitemid 44391754)
37. Weikert C, Dierkes J, Hoffmann K, et al. B vitamin plasma levels and the risk of ischemic stroke and transient ischemic attack in a German cohort. Stroke 2007;38:2912-2918. (Pubitemid 350035683)
38. Vanuzzo D, Pilotto L, Lombardi R, et al. Both vitamin B6 and total homocysteine plasma levels predict long-term atherothrombotic events in healthy subjects. Eur Heart J 2007;28:484-491. (Pubitemid 47343559)
39. Page JH, Ma J, Chiuve SE, et al. Plasma vitamin B6 and risk of myocardial infarction in women. Circulation 2009;120: 649-655.
40. Van Guelpen B, Hultdin J, Johansson I, et al. Plasma folate and total homocysteine levels are associated with the risk of myocardial infarction, independently of each other and of renal function. J Intern Med 2009;266:182-195.
41. Sofi F, Marcucci R, Bolli P, et al. Low vitamin B6 and folic acid levels are associated with retinal vein occlusion independently of homocysteine levels. Atherosclerosis 2008; 198:223-227. (Pubitemid 351410544)
42. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 1993;270: 2693-2698. (Pubitemid 23350966)
43. Arruda VR, von Zuben PM, Chiaparini LC, Annichino- Bizzacchi JM, Costa FF. The mutation Ala-677-Val in the MTHFR gene: a risk factor for arterial disease and venous thrombosis. Thromb Haemost 1997;77:818-821. (Pubitemid 27239096)
44. Wright AD, Martin N, Dodson PM. Homocysteine, folates, and the eye. Eye 2008;22:989-993.
45. Trope GE, Lowe GD, McArdle BM, et al. Abnormal blood viscosity and haemostasis in long-standing retinal vein occlusion. Br J Ophthalmol 1983;67:137-142. (Pubitemid 13144009)
46. Lerche RC, Wilhelm C, Eifrig B, Richard G. Thrombophilia factors as inducers of retinal vascular occlusion. Ophthalmologe 2001;98:529-534.
47. Faude F, Faude S, Siegemund A, Wiedemann P. Factor VIII activity in patients with central retinal vein occlusion in comparison to patients with a history of pelvic and lower limb venous thrombosis and a healthy control group. Klin Monatsbl Augenheilkd 2004;221:862-866. (Pubitemid 39490668)
48. Glueck CJ, Wang P, Bell H, Rangaraj V, Goldenberg N. Associations of thrombophilia, hypofibrinolysis, and retinal vein occlusion. Clin Appl Thromb Hemost 2005;11:375-389. (Pubitemid 41546764)
49. Farahvash MS, Moghaddam MM, Moghimi S, Mohammadz adeh S. Dalteparin in the management of recent onset central retinal vein occlusion: a comparison with acetylsalicylic acid. Can J Ophthalmol 2008;43:79-83. (Pubitemid 351269572)
50. Ageno W, Cattaneo R, Manfredi E, et al. Parnaparin versus aspirin in the treatment of retinal vein occlusion. A randomized, double blind, controlled study. Thromb Res 2010; 125:137-141.
51. Durga J, van Boxtel MP, Schouten EG, et al. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Lancet 2007;369:208-216. (Pubitemid 46107683)
52. Wang X, Qin X, Demirtas H, et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 2007;369:1876-1882. (Pubitemid 46829358)